Hudson, Florida (May 26, 2016) – Regional Medical Center Bayonet Point announces that it will conduct a series of lectures highlighting a new procedure to reduce the risk of stroke from atrial fibrillation. The goal would be the elimination of blood thinners (anti-coagulation medication). The first lecture will be on Watchman: What Everyone Needs to Know about Atrial Fibrillation & Stroke will be presented by Keshav Ramireddy, MD, at Fox Hollow, 10050 Robert Trent Jones Parkway in Trinity, Florida on Thursday, June 16.
Registration begins at 5 pm and a complimentary dinner will be served at 5:30 pm. Admission is free. Seating is limited and reservations are required. For more information and for reservations call 727-869-5498 or 888-741-5119.
About Regional Medical Center Bayonet Point
Regional Medical Center Bayonet has been serving the community since 1981. We are a 290-bed acute care hospital located in Hudson, FL and home of the nationally acclaimed Heart Institute. We have more than 350 physicians, 1,264 employees and 500 volunteers on our integrated healthcare delivery team.
Regional Medical Center Bayonet Point has achieved distinction in the following areas:
[if !supportLists]· [endif]Level II Trauma Center
[if !supportLists]· [endif]Accredited Chest Pain Center with PCI by the Society of Cardiovascular Patient Care
[if !supportLists]· [endif]2010, 2011, 2013 and 2014 Top Performing Hospital for Key Quality Measures for heart attack, heart failure, pneumonia, and surgical care – The Joint Commission
[if !supportLists]· [endif]Certified Advance Primary Stroke Center – Joint Commission
[if !supportLists]· [endif] 2014 and 2015 Top Performing Hospital for Key Quality Measures for heart attack, heart failure, pneumonia, surgical care, VTE and stroke – The Joint Commission
[if !supportLists]· [endif]Heart & Stroke Champions Award Winner 1998 – 2011
[if !supportLists]· [endif]MRI, CT, Ultrasound, and Nuclear Medicine Accredited – American College of Radiology
[if !supportLists]· [endif]Approved Community Cancer Program – American College of Surgeons
[if !supportLists]· [endif]5 Joint Commission Disease-Specific Certifications: primary stroke center, acute myocardial infarction, coronary artery bypass graft, joint replacement hip, joint replacement knee
[if !supportLists]· [endif]Awarded Hospital Safety Score of “A” in SIX consecutive rankings by The Leapfrog Group
[if !supportLists]· [endif]Recipient of the 2014 American Heart Association (AHA)/American Stroke Association’s Get With The Guidelines® Gold Performance Achievement Award in stroke
[if !supportLists]· [endif]Awarded full Atrial Fibrillation Certification status from the Society of Cardiovascular Patient Care (SCPC)
[if !supportLists]· [endif]Recipient of 2016 Blue Distinction® Center+ Designation for Quality and Cost-Efficiency in Cardiac Care
Regional Medical Center Bayonet Point is located at 14000 Fivay Road, Hudson, FL. 34667. For additional information on Regional Medical Center Bayonet Point visit www.rmchealth.com or www.heartoftampa.com or visit us on Facebook.
For patients with atrial fibrillation who are considered suitable for warfarin by their physicians but have reason to seek a non-drug alternative, the Watchman LAAC Implant is an implant alternative to reduce their risk of AF-related stroke. The WATCHMAN Implant closes off an area of the heart called the left atrial appendage (LAA) to keep harmful blood clots from the LAA from entering the blood stream and potentially causing a stroke. By closing off the LAA, the risk of stroke may be reduced and, over time, patients may be able to stop taking warfarin.
People with atrial fibrillation have a five times greater risk of stroke. Atrial fibrillation can cause blood to pool and form clots in the LAA. For patients with non-valvular AF, the LAA is believed to be the source of the majority of stroke-causing blood clots. If a clot forms in the LAA, it can increase one’s risk of having a stroke. Blood clots can break loose and travel in the blood stream to the brain, lungs, and other parts of the body.
WATCHMAN™ Left Atrial Appendage Closure Device from Boston Scientific
The WATCHMAN Device is a permanent implant designed to close the left atrial appendage in the heart in an effort to reduce the risk of stroke. With all medical procedures there are risks associated with the implant procedure and the use of the device. The risks include but are not limited to accidental heart puncture, air embolism, allergic reaction, anemia, anesthesia risks, arrhythmias, AV (Arteriovenous) fistula, bleeding or throat pain from the TEE (Trans Esophageal Echo) probe, blood clot or air bubbles in the lungs or other organs, bruising at the catheter insertion site, clot formation on the WATCHMAN™ Closure Device, cranial bleed, excessive bleeding, gastrointestinal bleeding, groin puncture bleed, hypotension, infection/pneumonia, pneumothorax, pulmonary edema, pulmonary vein obstruction, renal failure, stroke, thrombosis and transient ischemic attack. In rare cases death can occur. Be sure to talk with your doctor so that you thoroughly understand all of the risks and benefits associated with the implantation of the WATCHMAN Device.